Physician profile
William Miller
NPI 1003820655
$1,908.79
in general payments reported to CMS, 2019-2025
20 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.49 · 2022: $646 · 2023: $482 · 2024: $636 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,247.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $543.39 | 2022-2025 | Puraply Wound Matrix, Puraply, Novachor |
| Convatec INC. | $264.70 | 2023-2024 | |
| Triad Life Sciences INC. | $169.48 | 2022 | |
| Amgen INC. | $151.18 | 2024 | Krystexxa |
| Abbvie INC. | $143.57 | 2022-2024 | |
| Smith+Nephew, INC. | $129.88 | 2022-2023 | Grafix Pl |
| Inari Medical, INC. | $77.06 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Nevro Corp. | $76.20 | 2022-2023 | Senza |
| Horizon Therapeutics Plc | $70.05 | 2023 | Krystexxa |
| Averitas Pharma INC. | $65.34 | 2023-2025 | Qutenza |
| Paratek Pharmaceuticals, INC. | $37.17 | 2024 | Nuzyra |
| Ani Pharmaceuticals, INC. | $34.51 | 2025 | Purified Cortrophin Gel |
| Cashflow Solutions, LLC | $31.70 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Depuy Synthes Sales INC. | $26.44 | 2023 | Na, N/A |
| Nabriva Therapeutics, Plc | $17.96 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $15.49 | 2020 | |
| Medtronic, INC. | $15.05 | 2023 | Intellis Adaptivestim |
| Kerecis Limited | $14.64 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kowa Pharmaceuticals America, INC. | $12.88 | 2023 | Seglentis |
| Treace Medical Concepts, INC. | $12.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.